Cytotoxic Metabolites from a Colonizing Ascomycete
45% MeOH in H2O for 5 min followed by 45–60% for 25 min).
The fractions (1.0 g) eluted with 30–45% EtOAc were combined
and fractionated by Sephadex LH-20 CC using CH2Cl2/MeOH
(1:1) as eluent, and one of the subfractions (800 mg) was separated
again by silica gel CC (2ϫ13 cm) eluting with CH2Cl2/MeOH gra-
dients. One resulting subfraction (50 mg) eluted with 1% MeOH
In a similar fashion, a sample of 1 (2.0 mg, 0.008 mmol), CH2Cl2
(3.0 mL), DMAP (10.0 mg), and (R)-MTPACl (10.0 µL,
0.052 mmol) were allowed to react in a 10-mL round-bottomed
flask at room temperature for 18 h and the reaction mixture was
processed as described above for 1a to afford 1b (1.3 mg) as a white
powder. 1H NMR (500 MHz, CDCl3, 25 °C): δ = 5.93 (ddd, J =
was purified by RPHPLC to afford trichocladinol C (3; 10.0 mg, 10, 4.0, 3.0 Hz, 1 H, 8-H), 5.71 (dd, J = 10, 2.0 Hz, 1 H, 7-H), 5.18
tR = 18.70 min; 35% MeOH in H2O for 5 min followed by 35–50%
for 25 min) and another subfraction (20 mg) also eluted with 1%
MeOH was purified by RPHPLC using a different gradient (40%
(s, 1 H, 4-H), 4.44 (d, J = 4.0 Hz, 1 H, 10-H), 4.13 (t, J = 4.0 Hz,
1 H, 9-H), 4.08 (d, J = 12 Hz, 1 H, 1b-H), 3.96 (d, J = 12 Hz, 1
H, 1a-H), 2.50 (ddq, J = 7.5, 3.0, 2.0 Hz, 1 H, 6-H), 2.04 (s, 3 H,
MeOH in H2O for 5 min followed by 40–60% for 25 min) to afford 14-H), 1.37 (s, 3 H, 11-H), 0.98 (d, J = 7.5 Hz, 3 H, 12-H) ppm.
trichocladinol B (2; 4.0 mg, tR = 14.30 min) and massarigenin A
Trichocladinol B (2): Colorless oil. [α]2D2 = +141 (c = 0.06, CH3OH).
(4; 8.0 mg, tR = 16.00 min).
UV (CH3OH): λmax [log(ε/–1 cm–1)] = 203 [4.24] nm. IR (neat):
ν
= 3426 (br), 2942, 1708, 1439, 1393 cm–1. For 1H and 13C
˜
max
Trichocladinol
[5.2.1.03,8]dec-4-en-7-yl)methyl Acetate] (1): Colorless oil. [α]2D2
+78 (c = 0.03, CH3OH). UV (CH3OH): λmax [log(ε/–1 cm–1)] =
200 [3.62] nm. IR (neat): ν = 3465 (br), 2974, 1739, 1453, 1382,
A
[(10-Hydroxy-1,6-dimethyl-2,9-dioxatricyclo-
NMR spectroscopic data, see Table 1. HMBC data (400 MHz,
[D6]acetone, 25 °C): 4-H Ǟ C-6; 6-H Ǟ C-4, C-7, C-8, C-12; 7-H
Ǟ C-5, C-6, C-8, C-9, C-12; 9-H Ǟ C-5, C-7, C-10; 10-H Ǟ C-1,
C-3, C-4, C-9; 11-H Ǟ C-3, C-4; 12-H Ǟ C-5, C-6, C-7; 13-H Ǟ
C-1. NOESY correlations (400 MHz, [D6]acetone, 25 °C): 4-H ↔
12-H; 9-H ↔ 11-H. HRMS (ESI): calcd. for C12H16O5Na [M +
Na]+ 263.0890; found 263.0898.
=
˜
max
1242 cm–1. For H and 13C NMR spectroscopic data, see Table 1.
HMBC data (400 MHz, [D6]acetone, 25 °C): 1a-H Ǟ C-4, C-5, C-
6, C-10, C-13; 1b-H Ǟ C-13; 4-H Ǟ C-1, C-6; 6-H Ǟ C-4, C-5,
C-7, C-8, C-12; 7-H Ǟ C-5, C-6, C-8, C-9, C-12; 8-H Ǟ C-6, C-7,
C-9, C-10; 9-H Ǟ C-3, C-5, C-7, C-10; 10-H Ǟ C-3, C-4, C-5, C-
6, C-9; 11-H Ǟ C-3, C-4; 12-H Ǟ C-5, C-6, C-7; 14-H Ǟ C-13; 4-
OH Ǟ C-3, C-4, C-5. NOESY correlations (400 MHz, [D6]acetone,
25 °C): 4-H ↔ 12-H; 6-H ↔ 10-H; 4-OH ↔ 11-H. HRMS (ESI):
calcd. for C13H18O5Na [M + Na]+ 277.1046; found 277.1050.
1
Trichocladinol C (3): Colorless oil. [α]2D2 = +60 (c = 0.07, CH3OH).
UV (CH3OH) λmax [log(ε/–1 cm–1)] = 204 [3.95] nm. IR (neat):
ν
= 3489, 3320 (br), 2970, 1789, 1692, 1463, 1392 cm–1. For
˜
max
1H and 13C NMR spectroscopic data, see Table 1. HMBC data
(400 MHz, [D6]DMSO, 25 °C): 4-H Ǟ C-3, C-5, C-6, C-10, C-11;
6-H Ǟ C-4, C-5, C-8, C-10, C-12; 7a-H Ǟ C-8; 7b-H Ǟ C-5, C-
8, C-12; 8a-H Ǟ C-7, C-9; 8b-H Ǟ C-7; 9-H Ǟ C-10; 10-H Ǟ C-
1, C-4, C-5, C-9; 11-H Ǟ C-3, C-4; 12-H Ǟ C-5, C-6, C-7; 4-OH
Ǟ C-3, C-4, C-5; 9-OH Ǟ C-8, C-9, C-10; 10-OH Ǟ C-5, C-10.
NOESY correlations (400 MHz, [D6]DMSO, 25 °C): 4-H ↔ 10-
OH; 8a-H ↔ 12-H; 9-H ↔ 4-H, 7b-H; 10-H ↔ 8a-H, 12-H.
HRMS (ESI): calcd. for C11H16O5Na [M + Na]+ 251.0890; found
251.0892.
X-ray Crystallographic Analysis of 1: Upon crystallization from
acetone/H2O (10:1) using the vapor diffusion method, colorless
crystals were obtained for 1 and a crystal (0.58ϫ0.51ϫ0.45 mm)
was separated from the sample and mounted on a glass fiber, and
data were collected using a Rigaku R-AXIS RAPID IP dif-
fractometer with graphite-monochromated Mo-Kα radiation(λ =
0.71073 Å) at 173(2) K. Crystal data: C13H18O5, M = 254.27, space
group monoclinic, P21, unit cell dimensions: a = 7.3075(15), b =
9.2713(19), c = 10.017(2) Å, V = 638.1(2) Å3, Z = 2, Dcalcd.
=
Preparation of the (R)-MTPA Ester 3a and the (S)-MTPA Esters
3b and 3c: A sample of 3 (2.0 mg, 0.009 mmol) was dissolved in
CH2Cl2 (4.0 mL) in a 10-mL round-bottomed flask. DMAP
(10.0 mg) and (S)-MTPACl (10.0 µL, 0.052 mmol) were quickly
added and the flask was sealed and the contents stirred at room
temperature for 24 h. The mixture was evaporated to dryness and
purified by semipreparative RPHPLC (Agilent Zorbax SB-C18 col-
umn, 5 µm, 9.4ϫ250 mm, 80% CH3OH in H2O for 5 min followed
1.323 mgm–3, µ = 0.101 mm–1, F(000) = 272. The structure was
solved by direct methods using SHELXL-97[22] and refined by
using full-matrix least-squares difference Fourier techniques. All
non-hydrogen atoms were refined with anisotropic displacement
parameters and all hydrogen atoms were placed in idealized posi-
tions and refined as riding atoms with the relative isotropic param-
eters. Absorption corrections were performed by using the Siemens
Area Detector Absorption Program (SADABS).[23] The 5238 mea-
surements yielded 1555 independent reflections after equivalent
data had been averaged and Lorentz and polarization corrections
applied. The final refinement gave R1 = 0.0476 and wR2 = 0.1132
[IϾ2σ(I)].[24]
by 80–100% for 25 min, 2 mLmin–1) to afford 3a (1.2 mg, tR
=
22.50 min) as a white powder. 1H NMR (500 MHz, CDCl3, 25 °C):
δ = 6.47 (s,1 H, 4-H), 4.97 (d, J = 1.5 Hz, 1 H, 11b-H), 4.71 (td, J
= 10, 4.0 Hz, 1 H, 9-H), 4.68 (d, J = 1.5 Hz, 1 H, 11a-H), 4.14 (d,
J = 10 Hz, 1 H, 10-H), 2.25 (tt, J = 13, 5.0 Hz, 1 H, 7b-H), 2.07
(ddd, J = 7.0, 6.5, 5.0 Hz, 1 H, 6-H), 1.68 (ddd, J = 13, 6.5, 5.0 Hz,
1 H, 8b-H), 1.30 (ddd, J = 13, 10, 4.0 Hz, 1 H, 8a-H), 1.16 (ddd,
J = 13, 6.5, 4.0 Hz, 1 H, 7a-H), 1.08 (d, J = 7.0 Hz, 3 H, 12-
H) ppm.
Preparation of (R)- and (S)-MTPA Esters 1a and 1b: A sample of
1 (2.0 mg, 0.008 mmol) was dissolved in CH2Cl2 (3.0 mL) in a 10-
mL round-bottomed flask. DMAP (10.0 mg) and (S)-MTPACl
(10.0 µL, 0.052 mmol) were quickly added and the flask was sealed
and the contents stirred at room temperature for 24 h. The mixture
was evaporated to dryness and purified by semipreparative
RPHPLC (Agilent Zorbax SB-C18 column, 5 µm, 9.4ϫ250 mm;
In a similar fashion, a sample of 3 (2.0 mg, 0.009 mmol), CH2Cl2
(4.0 mL), DMAP (10.0 mg), and (R)-MTPACl (10.0 µL,
0.052 mmol) were allowed to react in a 10-mL round-bottomed
80% CH3OH in H2O for 5 min followed by 80–100% for 25 min, flask at room temperature for 18 h and the reaction mixture was
2 mLmin–1) to afford 1a (1.2 mg, tR = 16.30 min) as a white pow-
processed as described above for 3a to afford 3b (1.3 mg) and 3c
der. 1H NMR (500 MHz, CDCl3, 25 °C): δ = 5.94 (ddd, J = 10, (0.9 mg) as white powders. 3b: 1H NMR (500 MHz, CDCl3, 25 °C):
4.0, 3.0 Hz, 1 H, 8-H), 5.71 (dd, J = 10, 2.0 Hz, 1 H, 7-H), 5.19 δ = 6.58 (s, 1 H, 4-H), 4.92 (d, J = 1.5 Hz, 1 H, 11b-H), 4.70 (td,
(s,1 H, 4-H), 4.45 (d, J = 4.0 Hz, 1 H, 10-H), 4.13 (t, J = 4.0 Hz,
1 H, 9-H), 4.07 (d, J = 12 Hz, 1 H, 1b-H), 3.99 (d, J = 12 Hz, 1
H, 1a-H), 2.49 (ddq, J = 7.5, 3.0, 2.0 Hz, 1 H, 6-H), 2.05 (s, 3 H,
14-H), 1.32 (s, 3 H, 11-H), 1.00 (d, J = 7.5 Hz, 3 H, 12-H) ppm.
J = 10, 4.0 Hz, 1 H, 9-H), 4.55 (d, J = 1.5 Hz, 1 H, 11a-H), 4.22
(d, J = 10 Hz, 1 H, 10-H), 2.29 (tt, J = 13, 5.0 Hz, 1 H, 7b-H),
2.20 (ddd, J = 7.0, 6.5, 5.0 Hz, 1 H, 6-H), 1.67 (ddd, J = 13, 6.5,
5.0 Hz, 1 H, 8b-H), 1.44 (ddd, J = 13, 10, 4.0 Hz, 1 H, 8a-H), 1.32
Eur. J. Org. Chem. 2009, 5525–5530
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5529